Persistent URL of this record https://hdl.handle.net/1887/3754182
Documents
-
- Download
- 1-s2.0-S235230262300279X-main
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK) final results of a multicentre, phase 3, open-label, randomised trial
- All authors
- Chamuleau, M.E.D.; Stenner, F.; Chitu, D.A.; Novak, U.; Minnema, M.C.; Geerts, P.; Stevens, W.B.C.; Zenz, T.; Imhoff, G.W.V.; Wu, K.L.; Demandt, A.M.P.; Kersten, M.J.; Terpstra, W.E.; Tick, L.W.; Deeren, D.; Neste, E.V.; Gregor, M.; Veelken, H.; Boehmer, L.H.; Caspar, C.B.; Mutsaers, P.; Refos, J.M.; Sewsaran, R.; Fu, L.P.; Seefat, R.L.; Groot, C.A.U.D.; Dirnhofer, S.; Brand, M.V.; Jong, D. de; Nijland, M.; Lugtenburg, P.
- Date
- 2023-11-27
- Journal
- The Lancet Haematology
- Volume
- 10
- Issue
- 12
- Pages
- E966 - E975